metastatic liver cancer

Showing 1 - 25 of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Liver Cancer, Metastatic Liver Cancer, Benign Liver Tumors Trial

Not yet recruiting
  • Primary Liver Cancer
  • +3 more
    • (no location specified)
    Aug 1, 2023

    PDO/PDO-TIL/PDOTS for Drug Screen

    Recruiting
    • Liver Cancer
    • Metastatic Liver Cancer
    • Drug screen with PDO/PDO-TIL/PDOTS
    • Shanghai, Shanghai, China
      Zhongshan Hospital, Fudan University
    Jun 13, 2023

    Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Tumor Trial in Duarte (ECT204 T cells)

    Recruiting
    • Hepatocellular Carcinoma
    • +3 more
    • ECT204 T cells
    • Duarte, California
    • +1 more
    Jan 9, 2023

    Metastatic Liver Cancer Trial in Shanghai (HAIC?Bevacizumab?Camrelizumab)

    Not yet recruiting
    • Metastatic Liver Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 7, 2022

    Hepatocellular Carcinoma, Metastatic Liver Cancer Trial (BioTraceIO 360)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Metastatic Liver Cancer
    • BioTraceIO 360
    • (no location specified)
    Nov 29, 2022

    Hepatocellular Carcinoma, Metastatic Liver Cancer Trial (BioTraceIO 360)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Metastatic Liver Cancer
    • BioTraceIO 360
    • (no location specified)
    Oct 12, 2022

    Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)

    Recruiting
    • Hepatoblastoma
    • +5 more
    • ET140203 T Cells
    • Boston, Massachusetts
      Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Aug 12, 2022

    Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

    Recruiting
    • Hepatocellular Carcinoma
    • +3 more
    • ET140203 autologous T cell product
    • Duarte, California
    • +3 more
    Jul 1, 2022

    BioTraceIO Lite for Tissue Damage Assessment Following Liver

    Recruiting
    • Carcinoma, Hepatocellular
    • Metastatic Liver Cancer
    • BioTraceIO Lite
    • Phoenix, Arizona
    • +5 more
    Mar 23, 2022

    Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)

    Not yet recruiting
    • Liver Diseases
    • +27 more
    • Liver Transplantation
    • Murcia, Spain
      Felipe Alconchel
    Feb 24, 2022

    Colorectal Cancer, Metastatic Liver Cancer Trial in Shanghai (Anti-CEA CAR-T Cells)

    Recruiting
    • Colorectal Cancer
    • Metastatic Liver Cancer
    • Anti-CEA CAR-T Cells
    • Shanghai, Shanghai, China
      Department of Colorectal Surgery in Changhai Hospital
    Mar 9, 2022

    Treat Primary and Metastatic Liver Tumors

    Enrolling by invitation
    • Intrahepatic Cholangiocarcinoma
    • +3 more
      • Dallas, Texas
        Methodist Dallas Medical Center
      Feb 3, 2022

      Colorectal Cancer, Metastatic Liver Cancer, Liver Metastases Trial in Valencia (Liver transplantation)

      Recruiting
      • Colorectal Cancer
      • +2 more
      • Liver transplantation
      • Valencia, Spain
        Eva M Montalvá
      Sep 15, 2021

      Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in Duarte, Irvine, Sacramento (ET140202 autologous T cell product)

      Terminated
      • Hepatocellular Carcinoma
      • +3 more
      • ET140202 autologous T cell product
      • Duarte, California
      • +2 more
      Apr 14, 2021

      Chemotherapy for Resectable Colorectal Liver Metastases

      Completed
      • Metastatic Colorectal Cancer
      • Metastatic Liver Cancer
      • Liver resection and Neoadjuvant chemotherapy
      • +3 more
      • Reims, France
      • +8 more
      Mar 26, 2021

      Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (ET1402L1-ARTEMIS™ T cells -IV, ET1402L1-ARTEMIS™ T cells

      Completed
      • Hepatocellular Carcinoma
      • +3 more
      • ET1402L1-ARTEMIS™ T cells -IV
      • +2 more
      • Xi'an, China
        The First Affiliated Hospital of Xi'an Jiaotong University
      Mar 26, 2021

      Cancer, Lung, Perfusion Computed Tomography Target Lesion, Cancer Liver Trial in Ghent (Extra DCE-CT scan)

      Recruiting
      • Cancer, Lung
      • +4 more
      • Extra DCE-CT scan
      • Ghent, East-Flanders, Belgium
        University Hospital, Ghent
      Feb 8, 2021

      Primary Liver Cancer, Metastatic Liver Cancer Trial in Halifax (Primovist)

      Withdrawn
      • Primary Liver Cancer
      • Metastatic Liver Cancer
      • Halifax, Nova Scotia, Canada
        Nova Scotia Cancer Centre
      Jan 25, 2021

      Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (Sorafenib combined with ET140202-T cell, TAE combined with

      Unknown status
      • Hepatocellular Carcinoma
      • +3 more
      • Sorafenib combined with ET140202-T cell
      • +2 more
      • Xi'an, Shaanxi, China
        The First Affiliated Hospital of Xi'an Jiaotong University
      Aug 6, 2019

      Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Wuhan (autologous ET1402L1-CART cells)

      Terminated
      • Hepatocellular Carcinoma
      • +3 more
      • autologous ET1402L1-CART cells
      • Wuhan, Hubei, China
        Renmin Hospital of Wuhan University
      Jun 27, 2019

      Hepatocellular Cancer, Metastatic Liver Cancer Trial in Houston (TACE, Y-90, MWA)

      Terminated
      • Hepatocellular Cancer
      • Metastatic Liver Cancer
      • TACE
      • +3 more
      • Houston, Texas
        University of Texas Health Science Center Houston
      Oct 16, 2018

      Metastatic Liver Cancer, Secondary Liver Cancer, Liver Tumor Trial in New York, Cleveland (Radiofrequency Ablation (RFA),

      Withdrawn
      • Metastatic Liver Cancer
      • +2 more
      • New York, New York
      • +1 more
      Mar 2, 2017

      Metastatic Liver Cancer Trial in Philadelphia (SIRT, capecitabine)

      Completed
      • Metastatic Liver Cancer
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Sep 3, 2015

      Metastatic Liver Cancer Trial in Seoul (DCE MRI)

      Completed
      • Metastatic Liver Cancer
      • DCE MRI
      • Seoul, Korea, Republic of
        Asan Medical Center
      Jun 22, 2015

      Metastatic Liver Cancer, Ocular Melanoma, Cutaneous Melanoma Trial in United States (Melphalan, Percutaneous Hepatic Perfusion)

      No longer available
      • Metastatic Liver Cancer
      • +2 more
      • Santa Monica, California
      • +5 more
      Oct 22, 2013